Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)
Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $154.43
BioNTech SE's Strategic and Clinical Advancements Drive Buy Rating on BNT327's Promise in Oncology
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Announces Target Price $122
J.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
TheGerries : So when is our turn?
Den the Dragon : ,
Jaguar8 OP TheGerries : ???
103622690 DK : I really admire you, and I'm curious how you pick your watchlist from so many options, and even repeatedly select those with upward trends, leading to explosive gains the next day... I really want to learn from you, Master.
🫡
Jaguar8 OP 103622690 DK : If I have time and teach during weekends. It also takes experience to get the feel which stock are quite positive . There are misses too but often times they go up in the next days
View more comments...